Trials https://www.nct-dresden.de/en/trials https://www.nct-dresden.de/@@site-logo/logo-nct.svg Trials Kraniopharyngeom Registry 2019 LBL 2018 KPS-Register MNP Int R Nivolumab-NPC Anocca-VIDAR-1 Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer iHIT-HGG Register TroFuse ELEMENT (GBG 114) EmpowHER-303 PRSZT Register Genentech FORTREA IMCODE003 GO44479 CHONQUER IOV-MEL-301 AMG20210081 (CodeBreaK 301) Pacellio Pierre Fabre F60089IV101 VERT-002 INDIGO < Previous 20 items 1 ... 7 8 9 10 11 12 13 14 Next 20 items >
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer
